Marshall Islands vs Nauru: The number of people with susceptibility test result for rifampicin
Marshall Islands
100
in 2021
Nauru
100
in 2021
Marshall Islands rank
2nd
Nauru rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Marshall Islands
- Nauru
How they compare
Marshall Islands currently reports 100 against 100 in Nauru, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Marshall Islands ahead.
Marshall Islands ranks 2nd and Nauru ranks 2nd of 146 countries.
Marshall Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | Nauru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.97 | 0 | 96.97 | Marshall Islands |
| 2020s | 87.04 | 50 | 37.04 | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Marshall Islands or Nauru?
- Marshall Islands, at 100 against 100 in Nauru as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Marshall Islands and Nauru?
- 0, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Nauru?
- 5 years are reported by both, from 2017 to 2021.
- How do Marshall Islands and Nauru rank globally for the number of people with susceptibility test result for rifampicin?
- Marshall Islands ranks 2nd and Nauru ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.